1 Predictive value of clinical and laboratory features for the main febrile diseases in children living in Tanzania: A prospective observational study

2 reliability and validity of a chinese version of urinary tract infection symptom assessment questionnaire

3 aspectos epidemiológicos relacionados con la lactancia materna durante el primer año de vida

4 incidence and antibiotic susceptibility pattern of most common bacterial pathogen causing urinary tract infection (uti) in tehran, iran, 2012-2013

5 brazilian consensus on vesicoureteral reflux–recommendations for clinical practice

6 aspectos de la infección urinaria en el adulto

7 resultados de dois esquemas de tratamento da pielonefrite durante a gravidez e correlação com o desfecho da gestação results of two treatment regimens for pyelonephritis during pregnancy and correlation with pregnancy outcome

8 integrative review: evidences on the practice of intermittent/indwelling urinary catheterization revisión integrativa: evidencias en la práctica del cateterismo urinario intermitente/demora revisão integrativa: evidências na prática do cateterismo urinário intermitente/demora

9 chromogenic media for urine cultures can be cost-effective

10 uropathogenic escherichia coli (upec) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies

11 secondary or transient pseudohypoaldosteronism associated with urinary tract anomaly and urinary infection: a case report

12 antibiotic resistance and virulence phenotypes of recent bacterial strains isolated from urinary tract infections in elderly patients with prostatic disease

13 evaluación del recién nacido febril y predicción de infección del tracto urinario

14 Cranberry Proanthocyanidins-PANI Nanocomposite for the Detection of Bacteria Associated with Urinary Tract Infections

15 Community acquired urinary tract infections among adults in Accra, Ghana

16 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

17 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

18 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

19 Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

20 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

21 Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

22 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

23 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

24 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

25 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

26 Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

27 Community acquired urinary tract infections among adults in Accra, Ghana

28 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

29 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

30 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

31 Community acquired urinary tract infections among adults in Accra, Ghana

32 In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

33 Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

34 Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

35 Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections

36 Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

37 Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

38 Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

39 The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

40 Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

41 Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

42 Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

43 Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

44 Gaps in communication between different staff groups and older adult patients foster unnecessary antibiotic prescribing for urinary tract infections in hospitals: a qualitative translation approach.

45 Catheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention.

46 [An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].

47 [Single-dose amoxicillin, TMP-SMX and ofloxacin therapy in lower urinary tract infections].

48 GPs' attitudes towards the diagnosis and treatment of male urinary tract infections: a qualitative interview study in Ireland.

49 Preventing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit.

50 Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

51 Urinary tract infections and affecting factors detected in tobb university of economics and technology faculty of medicine hospital: A 5-year retrospective study

52 Extended Abstract: Multicenter Comparison of Safety and Efficacy of Cefprozil vs. Cefaclor in the Treatment of Acute and Uncomplicated Urinary Tract Infections

53 Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

54 A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

55 Use of Quinolones in Urinary Tract Infections and Prostatitis

56 A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

57 risk factors for postoperative urinary tract infections in patients undergoing total joint arthroplasty

58 cranberries for preventing urinary tract infections

59 extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

60 time-based distribution of staphylococcus saprophyticus pulsed field gel-electrophoresis clusters in community-acquired urinary tract infections

61 pathogen distribution and drug resistance of nephrology patients with urinary tract infections

62 long-term efficacy of fulguration of trigonitis for recurrent urinary tract infections in women

63 an exceptional source of recurrent urinary tract infections in women: primary retroperitoneal serous cystadenoma

64 antibiotic resistant urinary tract infections in an urology ward

65 incidence of fluoroquinolone resistance in pseudomonas aeruginosa from urinary tract infections

66 study of antagonistic effects of lactobacillus strains as probiotics on multi drug resistant (mdr) bacteria isolated from urinary tract infections (utis)

67 implementation of the urological guidelines for the treatment of urinary tract infections into the good practice of ukraine

68 lock-out valve to decrease catheter-associated urinary tract infections

69 process mapping in a pediatric emergency department to minimize missed urinary tract infections

70 complicated urinary tract infections: highlights on diagnosis and minimally invasive treatment

71 By ZEUS! Can We Use Intravenous Fosfomycin for Complicated Urinary Tract Infections?

72 Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

73 National Patterns in the Treatment of Urinary Tract Infections in Women by Ambulatory Care Physicians

74 Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens

75 Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group

76 Evolution of the Antimicrobial resistance of Bacteria causing Urinary Tract Infections

77 Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study

78 Genetic diversity and relationships among strains of Escherichia coli in the intestine and those causing urinary tract infections

79 Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections

80 Uropathogens and Gestational Outcomes of Urinary Tract Infections in Pregnancies that Necessitate Hospitalization.

Keyword Connections

Journals

Research Groups

Bibliographies